Qfitlia™ (fitusiran) – New orphan drug approval
March 28, 2025 - The FDA announced the approval of Sanofi’s Qfitlia (fitusiran), for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A or B with or without factor VIII or IX inhibitors.
Top